A1SI37 AF NFT

Glutamyl-tRNA reductase 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeid7c4333aq5lh6zrx2mriwrsip42rtyzjlmaxvhy3noedap76fjyi/metadata.json
IPFS of structure file: 
bafybeifznjvnpq7p4sfdzabwjcavrc63ihg33fit37uaskcxsrpuycv5am/AF-A1SI37-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x6191383F4eB2D51222b1165AcAF61154071b4A5B
First NFT owner address (bech32): 
genesis1vxgns06wkt23yg43zedv4as32sr3kjjmys9qpq
Current NFT ID #166414 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166414
Accession (UniProt):
A1SI37
Name::
Glutamyl-tRNA reductase 2
Experimental Method:
Predicted structure
Sequence source:
Nocardioides sp. (strain ATCC BAA-499 / JS614)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A1SI37 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A1SI37|HEM12_NOCSJ Glutamyl-tRNA reductase 2 OS=Nocardioides sp. (strain ATCC BAA-499 / JS614) OX=196162 GN=hemA2 PE=3 SV=1 MSRLTCLAFPGRSIPMAVLERLSVAARELPASVRALRAVPGVDQVLVLSTCERTEVYAWWTDEADPAALLRALAGQRGLGPEPLLEHAVGLTGREAVQHLLRVTAGLDSFVRGESDIVGQVRAAVQAARAEGAVGLEVQRLVDAAVNTSRRVHRSTGAGLAAGSVASTAVAAVAGLLPDGLAGRDLLVVGTGQVAVSVVAAAREAGARLTVCGRDPERAAAIAPAGARVLGLDDLPGALLDADAVVFGTSSPERLLRAGDLGPGLSEHRSGRELVVVDLCVPRNVDPDVRGVPGVRLLDLTDLRGAAVPGRRPSAPAPAALELAEQIVAQEVDRFLHWWVDRAAAEPVRRLRADVEACVREEVARATRGLSPDLEPLVAEGIRRAVQHLAHGPTRRLLDAAAAGEDEVVALLAGLFAPSAEEDQAVPAYSPQPIGNTSNAAASATPRR